Title: Enabling a Patient-Centered Approach: Large-Volume On-Body Infusors
The advancement in drug delivery device and formulation technology is opening up new opportunities for pharmaceutical companies to shift the current treatment paradigm for many patients.
Cincinnati-based Enable Injections is an investigational-stage company developing and manufacturing on-body subcutaneous infusion systems for combination products designed to help improve patient quality of life. Enable’s body-worn enFuse™ drug delivery platform utilizes any standard container closure system to deliver large-volume, high-viscosity pharmaceutical and biopharmaceutical therapeutics. The enFuse is designed to 1) be patient-friendly and improve the patient experience, 2) shift the treatments from hospital infusion clinics into the home, 3) improve patient adherence. The Enable Injections enFuse On-Body Platform differentiate's pharmaceutical portfolios and empowers patients to achieve improved outcomes
Session ID: 550889